ArticleDrug safety2005

Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme.

Mira Harrison-Woolrych et al.PubMed ↗Publisher ↗

No numbers read from the abstract.